Companies with the highest week-over-week lift in spend. In all cases, this looks at the leap from just the one week prior.
In the month of April, Ubrelvy invested $18.1mm in national television. This accounts for 99% of their monthly ad spend and airs on NBC, Fox, BET, TNT, and others. Week-over-Week their spend is up 9%.
This migraine prescription drug spent $17.4mm in television ad space in 2021 to date. Their campaign airs on ABC, CBS, Bravo, MTV, and others. Week-over-Week their spend is up 46%.
Zyrtec Allergy allocated 33% of their April spend to print. They invested $3.4mm with People, Shape, Southern Living, and others. This campaign features their “muddle through” allergies creative. Week-over-Week their spend is up 41%.
In the first month of Q2 2021, Eliquis spent $16.7mm in national television, print and digital ad space. Though the majority of their spend is invested into television, they did buy $106k of ads in B2B publications, like Emergency Medicine News and ACEP Now. Week-over-Week their spend is up 17%.
Thus far in 2021, Claritin-D invested 99% of their ad spend into national television. They spent $9.3mm with CBS, NBC, TV Land, FX, and others. Week-over-Week their spend is up 45%.
Until the third week of April, Cortizone-10 had no presence in the market. They invested $910k into national television appearing on Univision, ABC, Discover, MSNBC, and others. Week-over-Week their spend is up 200%.
Vicks ZzzQuil Pure Zzzs Melatonin Gummies
Vicks spent $6.4mm in television ad space in the first quarter of 2021. Their melatonin gummies product line ads only appeared on national TV. They aired on ESPN, History, Fox, Bravo, and others. Week-over-Week their spend is up 35%.
This analysis looks at ad placement in national broadcast & cable TV, digital (desktop & mobile), podcasts, weekly and monthly magazines, and daily newspapers in the largest 25 DMAs.